Designing of interferon-gamma inducing MHC class-II binders

Biology Direct

Volumn 8, Issue 1, 2013, Pages

  Dhanda, Sandeep Kumar ^a   Vir, Pooja ^a   Raghava, Gajendra P S ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; SUBUNIT VACCINE;

ANIMAL; ARTICLE; ARTIFICIAL INTELLIGENCE; BIOLOGY; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; EVALUATION STUDY; HUMAN; METHODOLOGY;

ANIMALS; ARTIFICIAL INTELLIGENCE; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON-GAMMA; MODELS, CHEMICAL; VACCINES, SUBUNIT;

EID: 84889053011     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-8-30     Document Type: Article

References (70)

1. Elhay MJ, Andersen P. Immunological requirements for a subunit vaccine against tuberculosis. Immunol Cell Biol 1997, 75:595-603. 10.1038/icb.1997.94, 9492199.
2. Andersen P, Doherty TM. TB subunit vaccines-putting the pieces together. Microbes Infection / Institut Pasteur 2005, 7:911-921.
3. Kaufmann SHE. Tuberculosis vaccine development: strength lies in tenacity. Trends Immunol 2012, 33:373-379. 10.1016/j.it.2012.03.004, 22560865.
4. Kanoi BN, Egwang TG. New concepts in vaccine development in malaria. Curr Opinion Infectious Dis 2007, 20:311-316.
5. Chitlaru T, Altboum Z, Reuveny S, Shafferman A. Progress and novel strategies in vaccine development and treatment of anthrax. Immunol Rev 2011, 239:221-236. 10.1111/j.1600-065X.2010.00969.x, 21198675.
6. Agarwal N, Padmanabh S, Vogelzang NJ. Development of novel immune interventions for prostate cancer. Clin Genitourin Cancer 2012, 10:84-92. 10.1016/j.clgc.2012.01.012, 22409862.
7. Beer M, Reimann I, Hoffmann B, Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007, 25:5665-5670. 10.1016/j.vaccine.2006.12.036, 17239502.
8. Sobolev BN, Poroǐkov VV, Olenina LV, Kolesanova EF, Archakov AI. Computer-assisted vaccine design. Biomedit{combining double inverted breve}sinskai{combining double inverted breve}a khimii{combining double inverted breve}a 2003, 49:309-332.
9. Zagursky RJ, Olmsted SB, Russell DP, Wooters JL. Bioinformatics: how it is being used to identify bacterial vaccine candidates. Expert Rev Vaccines 2003, 2:417-436. 10.1586/14760584.2.3.417, 12903807.
10. De Groot AS, Sbai H, Saint AC, McMurry J, Martin W. Immuno-informatics: mining genomes for vaccine components. Immunology Cell Biol 2002, 80:255-269.
11. Vivona S, Gardy JL, Ramachandran S, Brinkman FSL, Raghava GPS, Flower DR, Filippini F. Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. Trends Biotechnol 2008, 26:190-200. 10.1016/j.tibtech.2007.12.006, 18291542.
12. Roggen EL. Recent developments with B-cell epitope identification for predictive studies. J Immunotoxicol 2006, 3:137-149. 10.1080/15476910600845690, 18958694.
13. Saha S, Bhasin M, Raghava GPS. Bcipep: a database of B-cell epitopes. BMC Genomics 2005, 6:79. 10.1186/1471-2164-6-79, 1173103, 15921533.
14. Söllner J, Mayer B. Machine learning approaches for prediction of linear B-cell epitopes on proteins. J Mol Recognit 2006, 19:200-208. 10.1002/jmr.771, 16598694.
15. El-Manzalawy Y, Dobbs D, Honavar V. Predicting linear B-cell epitopes using string kernels. J Mol Recognit 2008, 21:243-255. 10.1002/jmr.893, 2683948, 18496882.
16. Ansari HR, Raghava GP. Identification of conformational B-cell Epitopes in an antigen from its primary sequence. Immunome Research 2010, 6:6. 10.1186/1745-7580-6-6, 2974664, 20961417.
17. Bublil EM, Freund NT, Mayrose I, Penn O, Roitburd-Berman A, Rubinstein ND, Pupko T, Gershoni JM. Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm. Proteins 2007, 68:294-304. 10.1002/prot.21387, 17427229.
18. Zhang W, Xiong Y, Zhao M, Zou H, Ye X, Liu J. Prediction of conformational B-cell epitopes from 3D structures by random forests with a distance-based feature. BMC bioinformatics 2011, 12:341. 10.1186/1471-2105-12-341, 3228550, 21846404.
19. Ponomarenko J, Bui H-H, Li W, Fusseder N, Bourne PE, Sette A, Peters B. ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC bioinformatics 2008, 9:514. 10.1186/1471-2105-9-514, 2607291, 19055730.
20. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, Bui H-H, Buus S, Frankild S, Greenbaum J, Lund O, Lundegaard C, Nielsen M, Ponomarenko J, Sette A, Zhu Z, Peters B. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 2008, 36(Web Server issue):W513-W518. 2447801, 18515843.
21. Lata S, Bhasin M, Raghava GPS. Application of machine learning techniques in predicting MHC binders. Methods Mol Biol (Clifton, NJ) 2007, 409:201-215.
22. Adams HP, Koziol JA. Prediction of binding to MHC class I molecules. J Immunol Methods 1995, 185:181-190. 10.1016/0022-1759(95)00111-M, 7561128.
23. Dönnes P, Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 2002, 3:25. 10.1186/1471-2105-3-25, 129981, 12225620.
24. Guan P, Doytchinova IA, Zygouri C, Flower DR. MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl Bioinformatics 2003, 2:63-66.
25. Reche PA, Glutting J-P, Zhang H, Reinherz EL. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004, 56:405-419.
26. Wan J, Liu W, Xu Q, Ren Y, Flower DR, Li T. SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics 2006, 7:463. 10.1186/1471-2105-7-463, 1626489, 17059589.
27. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009, 61:1-13. 10.1007/s00251-008-0341-z, 3319061, 19002680.
28. Dimitrov I, Garnev P, Flower DR, Doytchinova I. EpiTOP-a proteochemometric tool for MHC class II binding prediction. Bioinformatics (Oxford, England) 2010, 26:2066-2068.
29. Bhasin M, Raghava GPS. Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 2004, 22:3195-3204. 10.1016/j.vaccine.2004.02.005, 15297074.
30. Brusic V, Bajic VB, Petrovsky N. Computational methods for prediction of T-cell epitopes-a framework for modelling, testing, and applications. Methods (San Diego, Calif) 2004, 34:436-443.
31. Kangueane P, Sakharkar MK. T-Epitope designer: a HLA-peptide binding prediction server. Bioinformation 2005, 1:21-24. 10.6026/97320630001021, 1891623, 17597847.
32. Doytchinova IA, Flower DR. Class I T-cell epitope prediction: improvements using a combination of proteasome cleavage, TAP affinity, and MHC binding. Mol Immunol 2006, 43:2037-2044. 10.1016/j.molimm.2005.12.013, 16524630.
33. Tsurui H, Takahashi T. Prediction of T-cell epitope. J Pharmacol Sci 2007, 105:299-316. 10.1254/jphs.CR0070056, 18094522.
34. Schuler MM, Nastke M-D, Stevanovikć S. SYFPEITHI: database for searching and T-cell epitope prediction. Methods Mol Biol (Clifton, NJ) 2007, 409:75-93.
35. Feldhahn M, Dönnes P, Thiel P, Kohlbacher O. FRED-a framework for T-cell epitope detection. Bioinformatics (Oxford, England) 2009, 25:2758-2759.
36. Antonets DV, Maksiutov AZ. TEpredict: software for T-cell epitope prediction. Molekuliarnaia biologiia 2010, 44:130-139.
37. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics (Oxford, England) 2001, 17:1236-1237.
38. Zhang GL, DeLuca DS, Keskin DB, Chitkushev L, Zlateva T, Lund O, Reinherz EL, Brusic V. MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J Immunol Methods 2011, 374:53-61. 10.1016/j.jim.2010.11.009, 3090484, 21130094.
39. Bhasin M, Raghava GPS. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci 2007, 32:31-42. 10.1007/s12038-007-0004-5, 17426378.
40. Reche PA, Reinherz EL. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. Nucleic Acids Res 2005, 33(Web Server issue):W138-W142. 1160118, 15980443.
41. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994, 6:458-466. 10.1016/0952-7915(94)90128-7, 7917115.
42. Agnello D, Lankford CSR, Bream J, Morinobu A, Gadina M, O'Shea JJ, Frucht DM. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J Clin Immunol 2003, 23:147-161. 10.1023/A:1023381027062, 12797537.
43. Rincón M, Flavell RA. T-cell subsets: transcriptional control in the Th1/Th2 decision. Curr Biol 1997, 7:R729-R732. 10.1016/S0960-9822(06)00368-X, 9382795.
44. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis1999 Nov 5428594 1999, 5:285-294.
45. Andersen P, Doherty TM. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 2005, 3:656-662. 10.1038/nrmicro1211, 16012514.
46. Sable SB, Kalra M, Verma I, Khuller GK. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity. Clin Immunol Orlando Fla 2007, 122:239-251.
47. Wang L, Cai Y, Cheng Q, Hu Y, Xiao H. Imbalance of Th1/Th2 cytokines in patients with pulmonary tuberculosis. Zhonghua jie he he hu xi za zhi Zhonghua jiehe he huxi zazhi Chinese J Tuberc Respir Dis 2002, 25:535-537.
48. Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, Bah B, Benagiano M, Diallo A, Manetti R, Manneh K, Gustafson P, Bennett S, D'Elios MM, McAdam K, Del Prete G. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002, 32:1605-1613. 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6, 12115643.
49. Pfeiffer C. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995, 181:1569-1574. 10.1084/jem.181.4.1569, 2191965, 7699337.
50. Windhagen A, Scholz C, Höllsberg P, Fukaura H, Sette A, Hafler DA. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 1995, 2:373-380. 10.1016/1074-7613(95)90145-0, 7536622.
51. Nishimura Y, Chen YZ, Kanai T, Yokomizo H, Matsuoka T, Matsushita S. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification. Internal Med (Tokyo, Japan) 1998, 37:804-817.
52. Tamura T, Ariga H, Kinashi T, Uehara S, Kikuchi T, Nakada M, Tokunaga T, Xu W, Kariyone A, Saito T, Kitamura T, Maxwell G, Takaki S, Takatsu K. The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model. Int Immunol 2004, 16:1691-1699. 10.1093/intimm/dxh170, 15477229.
53. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res 2010, 38(Database issue):D854-D862. 2808938, 19906713.
54. R Development Core Team R: a language and environment for statistical computing 2009, Vienna, Austria: R Foundation for Statistical Computing, R Development Core Team.
55. Vacic V, Iakoucheva LM, Radivojac P. Two sample logo: a graphical representation of the differences between two sets of sequence alignments. Bioinformatics (Oxford, England) 2006, 22:1536-1537.
56. Redhead E, Bailey TL. Discriminative motif discovery in DNA and protein sequences using the DEME algorithm. BMC bioinformatics 2007, 8:385. 10.1186/1471-2105-8-385, 2194741, 17937785.
57. Vens C, Rosso M-N, Danchin EGJ. Identifying discriminative classification-based motifs in biological sequences. Bioinformatics (Oxford, England) 2011, 27:1231-1238.
58. Joachims T. Making Large Scale SVM Learning Practical. Univ., SFB 475 1998, 13.
59. Bhasin M, Raghava GPS. Pcleavage: an SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Res 2005, 33(Web Server issue):W202-W207. 1160263, 15988831.
60. Lam TH, Mamitsuka H, Ren EC, Tong JC. TAP Hunter: a SVM-based system for predicting TAP ligands using local description of amino acid sequence. Immunome Res 2010, 6(Suppl 1):S6.
61. Yao B, Zhang L, Liang S, Zhang C. SVMTriP: a method to predict antigenic epitopes using support vector machine to integrate tri-peptide similarity and propensity. PloS one 2012, 7:e45152. 10.1371/journal.pone.0045152, 3440317, 22984622.
62. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254. 10.1084/jem.178.6.2249, 2191274, 7504064.
63. Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opinion Microbiol 2001, 4:251-259.
64. Reljic R. IFN-gamma therapy of tuberculosis and related infections. J Interferon Cytokine Res 2007, 27:353-364. 10.1089/jir.2006.0103, 17523867.
65. Brower RC, England R, Takeshita T, Kozlowski S, Margulies DH, Berzofsky JA, Delisi C. Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol 1994, 31:1285-1293. 10.1016/0161-5890(94)90079-5, 7969189.
66. Cochran JR, Cameron TO, Stern LJ. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 2000, 12:241-250. 10.1016/S1074-7613(00)80177-6, 10755611.
67. Chang ST, Ghosh D, Kirschner DE, Linderman JJ. Peptide length-based prediction of peptide-MHC class II binding. Bioinformatics (Oxford, England) 2006, 22:2761-2767.
68. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanović S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219. 10.1007/s002510050595, 10602881.
69. Brusic V, Rudy G, Harrison LC. MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res 1998, 26:368-371. 10.1093/nar/26.1.368, 147255, 9399876.
70. Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, Buus S, Brunak S, Lund O. Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics (Oxford, England) 2004, 20:1388-1397.